254 related articles for article (PubMed ID: 12531981)
21. Activation of the T-cell oncogene LMO2 after gene therapy for X-linked severe combined immunodeficiency.
McCormack MP; Rabbitts TH
N Engl J Med; 2004 Feb; 350(9):913-22. PubMed ID: 14985489
[No Abstract] [Full Text] [Related]
22. The trials of gene therapy.
Nature; 2002 Nov; 420(6912):107. PubMed ID: 12432344
[No Abstract] [Full Text] [Related]
23. Looking into the safety of AAV vectors.
Kay MA; Nakai H
Nature; 2003 Jul; 424(6946):251. PubMed ID: 12867952
[No Abstract] [Full Text] [Related]
24. Second cancer case halts gene-therapy trials.
Check E
Nature; 2003 Jan; 421(6921):305. PubMed ID: 12540867
[No Abstract] [Full Text] [Related]
25. A tragic setback.
Check E
Nature; 2002 Nov; 420(6912):116-8. PubMed ID: 12432357
[No Abstract] [Full Text] [Related]
26. Temporary halt on gene therapy trials.
FDA Consum; 2003; 37(2):6. PubMed ID: 12715756
[No Abstract] [Full Text] [Related]
27. American Society of Gene Therapy meeting. Retroviral vectors: a double-edged sword.
Kaiser J
Science; 2005 Jun; 308(5729):1735-6. PubMed ID: 15961648
[No Abstract] [Full Text] [Related]
28. The leukemogenic risk of integrating retroviral vectors in hematopoietic stem cell gene therapy applications.
Kang EM; Tisdale JF
Curr Hematol Rep; 2004 Jul; 3(4):274-81. PubMed ID: 15217557
[TBL] [Abstract][Full Text] [Related]
29. Gene therapy resumes.
Novak K
Nat Rev Cancer; 2002 Nov; 2(11):813. PubMed ID: 12442759
[No Abstract] [Full Text] [Related]
30. US authorities uphold suspension of SCID gene therapy.
Fox JL
Nat Biotechnol; 2003 Mar; 21(3):217. PubMed ID: 12610555
[No Abstract] [Full Text] [Related]
31. Gene-therapy trials to restart following cancer risk review.
Check E
Nature; 2005 Mar; 434(7030):127. PubMed ID: 15758959
[No Abstract] [Full Text] [Related]
32. The future of gene therapy.
Cavazzana-Calvo M; Thrasher A; Mavilio F
Nature; 2004 Feb; 427(6977):779-81. PubMed ID: 14985734
[No Abstract] [Full Text] [Related]
33. Harmful potential of viral vectors fuels doubts over gene therapy.
Check E
Nature; 2003 Jun; 423(6940):573-4. PubMed ID: 12789298
[No Abstract] [Full Text] [Related]
34. Therapy on trial.
Hughes V
Nat Med; 2007 Sep; 13(9):1008-9. PubMed ID: 17828211
[No Abstract] [Full Text] [Related]
35. Gene therapy rising?
Hoag H
Nature; 2005 May; 435(7041):530-1. PubMed ID: 15917820
[No Abstract] [Full Text] [Related]
36. Is retroviral gene marking too dangerous to use?
Brenner MK; Heslop HE
Cytotherapy; 2003; 5(3):190-3. PubMed ID: 12850996
[No Abstract] [Full Text] [Related]
37. Trials are halted on gene therapy: child in experiment falls ill--new setback for research.
Stolberg SG
N Y Times Web; 2002 Oct; ():A1, A25. PubMed ID: 12474837
[No Abstract] [Full Text] [Related]
38. Too high a cost for a cure?
Boyce N
US News World Rep; 2002 Oct; 133(14):34. PubMed ID: 12389521
[No Abstract] [Full Text] [Related]
39. Panel advises resuming genetic studies: U.S. agency halted trials after boy fell ill in French experiment.
Stolberg SG
N Y Times Web; 2002 Oct; ():A30. PubMed ID: 12474841
[No Abstract] [Full Text] [Related]
40. Medicine. Gene therapy--new challenges ahead.
Williams DA; Baum C
Science; 2003 Oct; 302(5644):400-1. PubMed ID: 14563994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
